Cargando…
Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364362/ https://www.ncbi.nlm.nih.gov/pubmed/37488615 http://dx.doi.org/10.1186/s13046-023-02760-8 |
| _version_ | 1785076828220686336 |
|---|---|
| author | Li, Kai Peng, Zi-Yang Gao, Shan Wang, Qing-Shi Wang, Rui Li, Xiang Xiao, Guo-Dong Zhang, Jing Ren, Hong Tang, Shou-Ching Sun, Xin |
| author_facet | Li, Kai Peng, Zi-Yang Gao, Shan Wang, Qing-Shi Wang, Rui Li, Xiang Xiao, Guo-Dong Zhang, Jing Ren, Hong Tang, Shou-Ching Sun, Xin |
| author_sort | Li, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10364362 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103643622023-07-25 Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way Li, Kai Peng, Zi-Yang Gao, Shan Wang, Qing-Shi Wang, Rui Li, Xiang Xiao, Guo-Dong Zhang, Jing Ren, Hong Tang, Shou-Ching Sun, Xin J Exp Clin Cancer Res Correction BioMed Central 2023-07-24 /pmc/articles/PMC10364362/ /pubmed/37488615 http://dx.doi.org/10.1186/s13046-023-02760-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Li, Kai Peng, Zi-Yang Gao, Shan Wang, Qing-Shi Wang, Rui Li, Xiang Xiao, Guo-Dong Zhang, Jing Ren, Hong Tang, Shou-Ching Sun, Xin Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title | Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title_full | Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title_fullStr | Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title_full_unstemmed | Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title_short | Correction: M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| title_sort | correction: m6a associated tsuc7 inhibition contributed to erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364362/ https://www.ncbi.nlm.nih.gov/pubmed/37488615 http://dx.doi.org/10.1186/s13046-023-02760-8 |
| work_keys_str_mv | AT likai correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT pengziyang correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT gaoshan correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT wangqingshi correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT wangrui correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT lixiang correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT xiaoguodong correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT zhangjing correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT renhong correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT tangshouching correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway AT sunxin correctionm6aassociatedtsuc7inhibitioncontributedtoerlotinibresistanceinlungadenocarcinomathroughanotchsignalingactivationdependentway |